Text Size

Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?

This study has been withdrawn prior to enrollment.
(Stringent eligibility criterion caused difficulties in recruiting patients.)
Sponsor:
Information provided by:
KK Women's and Children's Hospital
ClinicalTrials.gov Identifier:
NCT00348166
First received: July 3, 2006
Last updated: October 3, 2011
Last verified: October 2011
History of Changes
  Purpose

The purpose of this study is to find out if undercorrection of myopia slow down the progression of myopia in kindergarten children.


Condition Intervention Phase
Refractive Error - Myopia
 Drug: cyclopentolate
 Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double-Blind
Official Title: Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by KK Women's and Children's Hospital:

Estimated Enrollment: 180
Study Start Date: December 2005
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   5 Years to 6 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Children of chinese descent aged 5 - 6yrs
  2. Refractive error of -1.00 to -3.00Ds
  3. Less than 1.50 astigmatism in each eye. (No oblique axis)
  4. Visual acuity is 6/6 or better in both eyes.
  5. No binocular problems, no anisometropia >1.50D
  6. Will be staying in S'pore for at least 2 years.

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00348166

Sponsors and Collaborators
KK Women's and Children's Hospital
Investigators
Principal Investigator: Quah Boon Long Singapore National Eye Centre
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00348166     History of Changes
Other Study ID Numbers: RAU/085/2005
Study First Received: July 3, 2006
Last Updated: October 3, 2011
Health Authority: Singapore: Domain Specific Review Boards

Additional relevant MeSH terms:
Myopia
Refractive Errors
Eye Diseases
Cyclopentolate
Mydriatics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
 Pharmacologic Actions
Parasympatholytics
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on May 16, 2013